Moderna Inc. got a new Wall Street-high price target from Goldman Sachs as its shares traded at a record after the biotech company revealed positive early results from its experimental vaccine for Covid-19.
Moderna Vaccine ‘Hits the Mark’ as Street Sees a Blockbuster
More Stories
How to land a good work-from-home job
Pfizer’s COVID-19 vaccine has begun rolling out of its Michigan plant in a truck convoy
Iran Sets Out Ambitions to Hike Oil Production Next Year